SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros Therapeutics, Inc. - RPRX

NEW YORK, Oct. 17, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Repros Therapeutics, Inc. ("Repros" or the "Company") RPRX (CUSIP: 76028H209).  Investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.

The investigation concerns whether Repros and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On September 26, 2014, Repros issued a press release reporting that it had been granted a Type B Pre-NDA meeting with the FDA in the first half of November, 2014.  According to the press release, the Company would seek guidance during this Type B meeting on its planned New Drug Application (NDA) for Androxal® for the treatment of secondary hypogonadism with preservation of testicular function.  The press release also indicated that Repros believed that the NDA for Androxal® would be filed around the end of 2014.  

However, on October 17, 2014, the Company reported that there isn't enough clinical information to hold a planned pre-investigational NDA meeting in November.  Instead, the Company said it will have a "type-C" guidance meeting with the FDA next month.    

On this news, shares of Repros fell $4.04, or more than 38.44%, on intraday trading to $6.47, on unusually heavy trading volume.

The Pomerantz Firm, with offices in New York, Chicago, San Diego, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

SOURCE Pomerantz LLP